Latest Content

First Patient Dosed With Annamycin and Cytarabine in Phase 3 AML Trial

April 1st 2025, 4:24pm

By Ryan Scott

Article

The first patient with relapsed or refractory acute myeloid leukemia has been dosed with Annamycin plus Cytarabine in the global phase 3 MIRACLE trial.

Second-Line Tovecimig Elicits Responses in Biliary Tract Cancer

April 1st 2025, 3:00pm

By Alex Biese

Article

Treatment with tovecimig, formerly known as CTX-009, elicited responses in patients with biliary tract cancer, according to COMPANION-002 study results.

Tagrisso May Improve Survival in Advanced EGFR-Mutant NSCLC

April 1st 2025, 1:13pm

By Alex Biese

Article

Tagrisso is associated with positive outcomes among patients with unresectable stage 3 EGFR-mutant non-small cell lung cancer.

Metastatic Kidney Cancer Requires a Multidisciplinary Approach to Care

March 31st 2025, 9:00pm

By Dr. William C. Huang

Video

CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.

COCOON Trial Regimen Reduces Dermatologic Side Effects in Mutated Lung Cancer

March 31st 2025, 8:00pm

By Spencer Feldman

Article

The COCOON trial regimen reduced dermatologic side effects in patients with EGFR-mutant non-small cell lung cancer, phase 2 trial data showed.

First-line Rybrevant Combo Extends Survival in Advanced Lung Cancer

March 31st 2025, 7:00pm

By Ryan Scott

Article

First-line Rybrevant plus Lazcluze significantly extended overall survival versus Tagrisso in mutated, advanced or metastatic non-small cell lung cancer.

The Positivity Trap of Follicular Lymphoma and Cancer

March 31st 2025, 5:00pm

By Karen Cohn

Article

As a lymphoma survivor, I struggle with the positivity trap — sometimes, I just want my fears validated instead of being reassured everything is fine.

Patient With Head and Neck Cancer Dosed in Trial of APR-1051

March 31st 2025, 4:02pm

By Alex Biese

Article

A patient with HPV-positive head and neck squamous cell carcinoma was dosed in a phase 1 clinical trial evaluating APR-1051.

Relacorilant Plus Chemo Meets Primary Goal in Ovarian Cancer Trial

March 31st 2025, 3:29pm

By Spencer Feldman

Article

The phase 3 trial showed relacorilant with chemotherapy improved progression-free and overall survival in platinum-resistant ovarian cancer.

Inside the Mind of a Bile Duct Cancer Survivor

March 31st 2025, 1:00pm

By Lisa Craine

Article

I’ve spent 14 years navigating recovery, mental health challenges and giving back to the cancer community through patient mentorship.

First Patient Dosed in Trial of [212Pb]VMT01 for Metastatic Melanoma

March 30th 2025, 6:00pm

By Ryan Scott

Article

The first patient has been dosed with [212Pb]VMT01 in a phase 1/2a trial evaluating the safety of the agent in patients with melanoma.

What Patients With Kidney Cancer Need to Know From ASCO GU

March 30th 2025, 2:00pm

By Alex Biese

Article

There were a number of notable developments for patients with kidney cancer at the symposium, Dr. Emre Yekedüz explained.

Research Shines Light on Disparities Across Breast Cancer Care

March 29th 2025, 2:00pm

By Dr. Regina Hampton

Video

Dr. Regina Hampton discusses key factors contributing to this disparity, and how healthcare systems can address these challenges.

FDA Approves Imfinzi Therapy in Muscle Invasive Bladder Cancer

March 28th 2025, 9:11pm

By Ryan Scott

Article

The FDA approved neoadjuvant Imfinzi, gemcitabine and cisplatin, followed by adjuvant Imfinzi after radical cystectomy in muscle invasive bladder cancer.

Life Goes On, Even With Breast Cancer

March 28th 2025, 8:00pm

By Laura Yeager

Article

I reflect on how cancer has brought out resilience and support in others, even as I struggled with my own battle, and wish others strength in their journeys.